A9P-19062-32616
2 vaccinations
2 coded responses
16 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 443 / OH
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-01-16
Registered in v-safe
-
2021-01-16
Dose 1 — Pfizer-BioNTech
- 2021-01-16
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-30
-
2021-02-06
Dose 2 — Pfizer-BioNTech
-
2021-02-13
Health check-in — day 7, dose 2Feeling: Good · Site: Pain, Redness, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to workAdult check-in
-
2021-02-20
Survey response — day 14, dose 2MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-05-08
- 2021-08-09
-
2022-02-08
Survey response — 12 months, dose 2MedDRA: Emergency care, Muscular weakness, Neurological symptom, Tremor — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Transient stroke-like symptoms (ED visit), muscle weakness and tremors that are not attributed to any underlying condition, despite evaluation of many possible conditions.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-08
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-02-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Pfizer-BioNTech | |
| 2 | 2021-02-06 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — day 14, dose 2
Symptoms: Fatigue
Release 11 — 12 months, dose 2
Symptoms: Transient stroke-like symptoms (ED visit), muscle weakness and tremors that are not attributed to any underlying condition, despite evaluation of many possible conditions.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Emergency care | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Neurological symptom | · | · | ✓ |
| SD | Tremor | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release